Cosciens Biopharma Inc.
13F holders, Q2 2025 (June 30)15holders
1new positions
1sold out
$3.37avg. 13F price*
At the end of Q2 2025, 15 institutions reported holding Cosciens Biopharma Inc. in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were Susquehanna International Group, LLP ($39K), Royal Bank of Canada ($14K) and TD Waterhouse Canada Inc. ($13K).
- Company
- Cosciens Biopharma Inc.
- CUSIP
- 22112H101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $7 |
| Exits | 1 | $141 |
All 13F filers, Q1 2025 → Q2 2025: 576 shares bought and 832 shares sold, net −256 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Susquehanna International Group, LLP | 0.00% | Reduce -3.4% | 11,504 | $39K |
| Royal Bank of Canada | 0.00% | Add +9.6% | 4,239 | $14K |
| TD Waterhouse Canada Inc. | 0.00% | Add +3.9% | 3,860 | $13K |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -13.4% | 2,435 | $8K |
| UBS Group AG | 0.00% | Add +1.4% | 2,369 | $8K |
| National Bank of Canada | 0.00% | Add +2.4% | 1,149 | $4K |
| Morgan Stanley | 0.00% | Reduce -0.4% | 500 | $2K |
| MAI Capital Management | 0.00% | No change | 401 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 165 | $561 |
| BNP Paribas Financial Markets | 0.00% | No change | 100 | $339 |
| Osaic Holdings, Inc. | 0.00% | No change | 50 | $168 |
| Group One Trading LLC | 0.00% | No change | 37 | $125 |
| Truvestments Capital LLC | 0.00% | No change | 22 | $75 |
| Raymond James Financial Inc. | 0.00% | New | 2 | $7 |
| Groupe la Francaise | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is COSCIENS BIOPHARMA INC's weight in each manager's 13F, not the share of Cosciens Biopharma Inc. the manager owns.